Cas:1903-27-1 2-Cyclopentylideneacetic acid manufacturer & supplier

We serve Chemical Name:2-Cyclopentylideneacetic acid CAS:1903-27-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Cyclopentylideneacetic acid

Chemical Name:2-Cyclopentylideneacetic acid
CAS.NO:1903-27-1
Synonyms:2-cyclopentylideneacetic acid;CYCLOPENTYLIDENEACETIC ACID
Molecular Formula:C7H10O2
Molecular Weight:126.15300
HS Code:2916209090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:37.30000
Exact Mass:126.06800
LogP:1.57140

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-cyclopentylideneacetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,CYCLOPENTYLIDENEACETIC ACID physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-cyclopentylideneacetic acid Use and application,2-cyclopentylideneacetic acid technical grade,usp/ep/jp grade.


Related News: The Philippines reported its first Wuhan coronavirus fatality on Sunday. 2-Cyclopentylideneacetic acid manufacturer By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 2-Cyclopentylideneacetic acid supplier In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. 2-Cyclopentylideneacetic acid vendor By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 2-Cyclopentylideneacetic acid factory By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.